<?xml version="1.0" encoding="UTF-8"?>
<codeBook version="2.5" ID="FRESH-PEF80-en" xml-lang="en" xmlns="ddi:codebook:2_5" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="ddi:codebook:2_5 https://ddialliance.org/Specification/DDI-Codebook/2.5/XMLSchema/codebook.xsd">
<docDscr>
  <citation>
    <titlStmt>
      <titl>Observational study: Conditions of use of duloxetine in France</titl>
      <IDNo>FRESH-PEF80-en</IDNo>
    </titlStmt>
    <prodStmt>
      <producer abbr="" affiliation="LILLY FRANCE" role="">Béatrice AUGENDRE-FERRANTE</producer>
    </prodStmt>
    <verStmt>
      <version></version>
    </verStmt>
  </citation>
</docDscr>
<stdyDscr>
  <citation>
    <titlStmt>
      <titl>
                Observational study: Conditions of use of duloxetine in France            </titl>
      <altTitl>
                    B030                </altTitl>
      <IDNo agency="FReSH-lang">
                FRESH-PEF80-en            </IDNo>
      <IDNo agency="PEF">
                    80                </IDNo>
      <IDNo agency="FReSH">
                    FRESH-PEF80                </IDNo>
    </titlStmt>
    <rspStmt>
      <othId affiliation="" type="">
                                    </othId>
    </rspStmt>
    <prodStmt>
      <producer role="sponsor">
                                            LILLY FRANCE                    
                                    </producer>
      <prodPlac>
                Epidemiology France Portal (PEF)            </prodPlac>
      <fundAg>
                                            AGENCE NATIONALE DE RECHERCHES SUR LE SIDA ET LES HEPATITES VIRALES (ANRS MIE)                    
                                    </fundAg>
    </prodStmt>
    <distStmt>
      <distrbtr abbr="null">
                    null</distrbtr>
      <contact affiliation="" email="">
                    
                                    </contact>
      <depDate date="2026-05-25"/>
      <distDate date="2026-05-25"/>
    </distStmt>
    <biblCit format="">
            </biblCit>
    <holdings URI="null"/>
    <notes> </notes>
  </citation>
  <stdyInfo><studyBudget/><subject><keyword vocab="" vocabURI="">
                    Pharmacy</keyword><keyword vocab="" vocabURI="">
                    appropriate use</keyword><keyword vocab="" vocabURI="">
                    duloxetine</keyword><keyword vocab="" vocabURI="">
                    conditions of use</keyword><topcClas vocab="health theme">
                        Psychiatry                                                        <ExtLink title="ESV" URI="http://data.europa.eu/8mn/euroscivoc/3de50dee-da1c-4791-a386-56bca24a5fed"/>
                                                            <ExtLink title="MeSH" URI="http://id.nlm.nih.gov/mesh/D011570"/>
                                                </topcClas><topcClas vocab="cim-11">
                        Depressive disorders                                            </topcClas><topcClas vocab="health determinant">
                        Healthcare system determinants: Use of care                    </topcClas><topcClas vocab="health determinant">
                        Healthcare system determinants                    </topcClas></subject>

        Primary objective: evaluate the conditions for use of duloxetine in routine practice; Secondary objectives: characteristics of the patients treated by duloxetine, profiles of duloxetine prescribers, characteristics of treatment.<abstract contentType="purpose">null</abstract>        <abstract contentType="abstract">null</abstract>
        <sumDscr><collDate event="start" date="2009-01-01"/><collDate event="end" date="2010-01-01"/><nation abbr="fr">
                    France
                                            <concept vocab="ISO" vocabURI="fr"/>
                                    </nation><geogUnit/><anlyUnit>
                Individuals            </anlyUnit><universe level="type" clusion="I">Patients population                    </universe><universe level="sex" clusion="I">Male                                                            <concept vocab="MeSH" vocabURI="http://id.nlm.nih.gov/mesh/D008297"/>
                                                    </universe><universe level="sex" clusion="I">Female                                                            <concept vocab="MeSH" vocabURI="http://id.nlm.nih.gov/mesh/D005260"/>
                                                    </universe><universe level="age" clusion="I">Young Adult (19 to 24 years)                                                            <concept vocab="MeSH" vocabURI="http://id.nlm.nih.gov/mesh/D055815"/>
                                                    </universe><universe level="age" clusion="I">Adult (25 to 44 years)                                                            <concept vocab="MeSH" vocabURI="http://id.nlm.nih.gov/mesh/D000328"/>
                                                    </universe><universe level="age" clusion="I">Middle Aged (45 to 64 years)                                                            <concept vocab="MeSH" vocabURI="http://id.nlm.nih.gov/mesh/D008875"/>
                                                    </universe><universe level="age" clusion="I">Aged (65 to 79 years)                                                            <concept vocab="MeSH" vocabURI="http://id.nlm.nih.gov/mesh/D000368"/>
                                                    </universe><universe level="age" clusion="I">Aged, 80 and over (80 years and more)                                                            <concept vocab="MeSH" vocabURI="http://id.nlm.nih.gov/mesh/D000369"/>
                                                    </universe><universe clusion="I">Patient receiving duloxetine in a pharmacy regardless of the indication, whether treatment initiation or renewal                    </universe><dataKind>Clinical data</dataKind></sumDscr>
                
        



        

    </stdyInfo>
  <studyDevelopment>
    <developmentActivity type="primary evaluation">
      <description>Health event/morbidity</description>
    </developmentActivity>
  </studyDevelopment>
  <method>
    <dataColl>
      <timeMeth>One-time cross-sectional study</timeMeth>
      <sampProc>Probability: Stratified                                                            <concept vocab="CESSDA" vocabURI="Probability.Stratified"/>
                                                    </sampProc>
      <sampleFrame>
        <frameUnit>
          <unitType>Population database for statistical purposes</unitType>
        </frameUnit>
      </sampleFrame>
      <targetSampleSize>
        <sampleSizeFormula>&lt; 500 individuals                        </sampleSizeFormula>
      </targetSampleSize>
      <collMode>Converting or copying information into a structured record                                                            <concept vocab="CESSDA" vocabURI="Transcription"/>
                                                    </collMode>
    </dataColl>
    <notes>Observational Study</notes>
    <notes subject="research type">
                        Observational Study                    </notes>
    <anlyInfo>
      <respRate>294</respRate>
    </anlyInfo>
    <stdyClas>Completed study</stdyClas>
  </method>
  <dataAccs>
    <setAvail>
      <avlStatus>
                            Restricted access                                                    </avlStatus>
    </setAvail>
  </dataAccs>
  <othrStdyMat>
    <relMat>Access on specific project only</relMat>
  </othrStdyMat>
</stdyDscr>
<dataDscr>
</dataDscr></codeBook>
